Combes Alexander D, Palma Catalina A, Calopedos Ross, Wen Lingfeng, Woo Henry, Fulham Michael, Leslie Scott
Department of Urology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Department of Molecular Imaging, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Diagnostics (Basel). 2022 Oct 26;12(11):2594. doi: 10.3390/diagnostics12112594.
Prostate cancer is the most common cancer and the second leading cause of cancer death in men. The imaging assessment and treatment of prostate cancer has vastly improved over the past decade. The introduction of PSMA PET-CT has improved the detection of loco-regional and metastatic disease. PSMA PET-CT also has a role in the primary diagnosis and staging, in detecting biochemical recurrence after curative treatment and in metastasis-directed therapy. In this paper we review the role of PSMA PET-CT in prostate cancer.
前列腺癌是男性中最常见的癌症,也是癌症死亡的第二大主要原因。在过去十年中,前列腺癌的影像学评估和治疗有了很大改善。PSMA PET-CT的引入提高了对局部区域和转移性疾病的检测能力。PSMA PET-CT在前列腺癌的初步诊断和分期、检测根治性治疗后的生化复发以及转移导向治疗中也发挥着作用。在本文中,我们综述了PSMA PET-CT在前列腺癌中的作用。